These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 5763482)

  • 1. Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.
    Prichard BN
    Proc R Soc Med; 1969 Jan; 62(1):84-91. PubMed ID: 5763482
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of propranolol and guanethidine on the circulatory adaptation in the Finnish sauna.
    Iisalo E; Kanto J; Pihlajamäki K
    Ann Clin Res; 1969 Dec; 1(4):251-5. PubMed ID: 5371911
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of antihypertensive drug therapy.
    Brest AN; Onesti G; Swartz C; Seller R; Kim E; Chinitz J
    JAMA; 1970 Jan; 211(3):480-4. PubMed ID: 5466923
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of alpha-methyldopa and guanethidine on the blood pressure of the pithed rat.
    Noach EL; Hillen FC; de Groot MA
    Arch Int Pharmacodyn Ther; 1971 Feb; 189(2):403-4. PubMed ID: 5548785
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained dilatation elicited by sympathetic nerve stimulation.
    Beck L; Pollard AA; Kayaalp SO; Weiner LM
    Fed Proc; 1966; 25(6):1596-606. PubMed ID: 5927392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive agents acting on the nervous system. 3: peripheral action].
    Béroniade V
    Union Med Can; 1982 Jan; 111(1):49-54. PubMed ID: 7058570
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current antihypertensive drugs: mechanism of action].
    Perrier CV; Sitavanc L
    Schweiz Med Wochenschr; 1973 Nov; 103(47):1678-86. PubMed ID: 4150373
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of reflex sympathetic nervous system activity in man on guanethidine or reserpine.
    Coffman JD
    Circulation; 1967 Feb; 35(2):339-46. PubMed ID: 6022802
    [No Abstract]   [Full Text] [Related]  

  • 9. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
    Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S51-5. PubMed ID: 3007706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive drugs for the aging.
    Hammond JJ; Kirkendall WM
    Geriatrics; 1979 Jun; 34(6):27-36. PubMed ID: 36328
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihypertensive drugs that alter adrenergic function.
    Weinshilboum RM
    Mayo Clin Proc; 1980 Jun; 55(6):390-402. PubMed ID: 6103981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hypotensive, orthostatic and sympathetic inhibitory actions of antihypertensive drugs in rats.
    Baum T; Sabin C; Moran RM
    Clin Exp Hypertens (1978); 1981; 3(2):219-43. PubMed ID: 7215067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine).
    Baum T; Shropshire AT; Varner LL
    J Pharmacol Exp Ther; 1972 Jul; 182(1):135-44. PubMed ID: 5041650
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of sympathetic function inhibition and its importance in the treatment of hypertension].
    Muscholl E
    Internist (Berl); 1966 Aug; 7(8):405-13. PubMed ID: 4863413
    [No Abstract]   [Full Text] [Related]  

  • 16. Fate of norepinephrine in sympathetic nerons and by cardiovascular drugs.
    Axelrod J; Wurtman RJ
    N Y State J Med; 1968 Jan; 68(2):252-6. PubMed ID: 4383958
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormal respiratory control in acquired dysautonomia.
    Eisele JH; Cross CE; Rausch DC; Kurpershoek CJ; Zelis RF
    N Engl J Med; 1971 Aug; 285(7):366-8. PubMed ID: 5556575
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses.
    Prichard BN; Gillam PM; Graham BR
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):131-40. PubMed ID: 4924319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Central effects of some adrenergic blocking and-or sympatholytic substances. II. Action on spontaneous motility and potentialization of pentobarbital].
    Boissier JR; Simon P; Giudicelli JF
    Arch Int Pharmacodyn Ther; 1967 Oct; 169(2):312-9. PubMed ID: 6064561
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of beta-adrenergic blocking substances on muscle bloodflow in man.
    Schoop W; Schmidtke I
    Angiologica; 1966; 3(3):143-52. PubMed ID: 5936214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.